Associated Papers
Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia.
Donato NJ et al.
Biochemical Pharmacology, 2010
Select a paper to view details